Skip to search formSkip to main contentSkip to account menu

AP25 peptide

Known as: ES-2 peptide, isoleucyl-valyl-arginyl-arginyl-alanyl-aspartyl-arginyl-alanyl-alanyl-valyl-proline, Ile-Val-Arg-Arg-Ala-Asp-Arg-Ala-Ala-Val-Pro 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

EndostatinsPeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Effects of the anti-angiogenic carbohydrate-peptide conjugate, chitooligosaccharide-ES2 on endothelial cells and tumor-bearing mice.
2019
2019
Characterization, bioactivity and pharmacokinetic study of a novel carbohydrate-peptide polymer: Glycol-split heparin-endostatin2 (GSHP-ES2).
2018
2018
Hyaluronic acid‐endostatin2‐alft1 (HA‐ES2‐AF) nanoparticle‐like conjugate for the target treatment of diseases
2014
2014
28-C-ES-2 薬学的介入の実際と症例サマリ : 胃がん(がん治療における薬学的介入の実際と症例サマリのまとめ方,教育セミナー,新時代を拓く医療薬学フロンティア)
2014
2014
ES-2 医学生・初期研修医に対してどのような外科教育が望ましいか : 日米の経験を通じて(ES 教育セッション,第114回日本外科学会定期学術集会)
2010
2010
Effect of RGD-4C position is more important than disulfide bonds on antiangiogenic activity of RGD-4C modified endostatin derived synthetic polypeptide.
ES-2 (IVRRADRAAVP), an endostatin-derived synthetic polypeptide, contains the amino acids 50-60 of endostatin from its N terminus… 
2004
2004
ES-2 臨床試験の企画,運営に必要な生物統計の考え方 : がんの臨床研究を中心に
2001
2001
ES-2 誤陽性にとられやすい乳腺の良性疾患 : 腺腫
2000
2000
ES-2 体内膜細胞診疑陽性判定の現状と今後の展望 : 施設における集検成績を中心に
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)